SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2457V Roy, ans second half of 2018 options are gone. secfilings.nasdaq.com It was pMiljenko Zuanic-7/12/2018
2456hugin.info Off-label opportunity for Kevzara!Miljenko Zuanic-6/29/2018
2455Chairman is special issue, still way OVERPAY! Also, am not sure what he did allMiljenko Zuanic-6/26/2018
2454I can't believe how much they pay members of the board....Felix B-6/25/2018
2453RE Dupi: NICE finial blessing, price at "£1,264.89 per pack of 2x2 ml Miljenko Zuanic-6/22/2018
2452VPR, This is not a rush, but also it is not end-of-year confidence as well!? invMiljenko Zuanic-6/22/2018
2451With start of the GBM trial, is REGN interested in vaccine or IL-12 pro-drug? imMiljenko Zuanic-6/22/2018
2450Another story on canakinumab (Ilaris). Effect on lung cancer: theoncologist.alpMiljenko Zuanic-6/19/2018
2449governor.ny.gov Infectious program initiatives from(for) REGN!Miljenko Zuanic-6/19/2018
2448I never know what to make of technical analysis...Felix B-6/19/2018
2447To stop development of the Arcalyst (IL-1beta trap) ...was a good decision, as cMiljenko Zuanic-6/16/2018
2446Remind me, they stopped developing arclyst for royalties?Felix B-6/16/2018
2445RE: JAK1/2 for "at risk": Message 31659561Miljenko Zuanic-6/15/2018
2444RE: anti-IL-1 endpts.com Arcalyst was discontinued for gout, now Ilaris (NVS) Miljenko Zuanic-6/14/2018
2443Well, combo is needed to achieve meaningful numbers of CRs as well as durable PRMiljenko Zuanic-6/13/2018
2442Their commercialization efforts have been lackluster, perhaps the new chief of cFelix B-6/12/2018
2441Based on pre-clinical REGN2810 data, it is. Will they be able to monetize it, itMiljenko Zuanic-6/12/2018
2440So do you think there is any hope for REGN in the I/O field?Felix B-6/12/2018
2439Keytruda approved for cervical cancer based on ORR, while REGN is doing overall Miljenko Zuanic-6/12/2018
2438Not quite like buying shares on the open market, but I will take it! I continueBiotech Jim-6/12/2018
2437First lot of Sanofi holding landed in REGN hand! secfilings.nasdaq.comMiljenko Zuanic-6/12/2018
2436Yan at Byram Hills, and other ....With all this continuous presentation here andMiljenko Zuanic-6/8/2018
2435Was this supposed to be a specific link to something or just a link to their twiFelix B-6/8/2018
2434I did not want this to post on twitter, but they do deserve it! twitter.com WhMiljenko Zuanic-6/8/2018
2433investor.regeneron.com Animal business,....whatever can be extracted from businMiljenko Zuanic-6/6/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News